Skip to main content

SMITH, MOORE & CO.

Position in GILD — Gilead Sciences, Inc.

CIK 200724 CLAYTON, MO

Position in GILD

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$205,431
-$1,263 QoQ
Shares Held
1,474
-12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $205,431 1,474
2025-12-31 $206,694 1,684
2025-09-30 $230,991 2,081
2025-06-30 $230,055 2,075
2025-03-31 $238,666 2,130
2024-12-31 $289,118 3,130
2024-09-30 $261,077 3,114
2024-06-30 $212,210 3,093
2024-03-31 $228,613 3,121
2023-12-31 $235,415 2,906
2023-09-30 $218,824 2,920
2023-06-30 $224,967 2,919
2023-03-31 $229,660 2,768
2022-12-31 $237,632 2,768